SS13: Clinical Science: Special Reports

Updated:Oct 13,2014
Science News 2013 Sessions header 600x123 
 

Clinical Science: Special Reports

QUICK LINKS:
CS.01: Application of Cell-Based Therapies to Treat Cardiac and Peripheral DiseasesCS.02: Biomarkers in PopulationsCS.03: Novel Approaches to Treating Hypertension and AtherosclerosisCS.04: Advanced Cardiovascular Disease: Complications and Challenges


CS.01: Application of Cell-Based Therapies to Treat Cardiac and Peripheral Diseases
ss13_therapeutics_headshot
Gerald W. Dorn

St. Louis, MO
State of the Art: Cardiac Stem Cell Therapeutics from the Outside, Looking In

Presentation Slides | Presentation Audio 
ss13_lvadbridge_headshot
April Stempien-Otero

University of Washington School of Medicine, Seattle, WA
Mechanisms of Bone Marrow Derived Cell Therapy in Ischemic Cardiomyopathy with Left Ventricular Assist Device (LVAD) Bridge to Transplant

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_tac-hft_headshot
Joshua M. Hare

Univ of Miami, Miami, FL
Assessment of Safety and Efficacy of Autologous Mesenchymal Stem Cells and Whole Bone Marrow in Patients with Ischemic Cardiomyopathy: The TAC-HFT Trial

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_allogeic_headshot
Deborah D. Ascheim

Icahn Sch of Med at Mount Sinai, New York, NY
Intramyocardial Injection of Allogeneic Mesenchymal Precursor Cells in Left Ventricular Assist Device Patients

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_time_headshot
Jay H. Traverse

Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital
Minneapolis, MN
The NHLBI TIME Trial: One-Year Results

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_sitagrami_headshot
Wolfgang M. Franz

Medizinische Universität Innsbruck
Innsbruck, Austria
Safety And Efficacy Of Sitagliptin Plus Granulocyte-colony Stimulating Factor In Patients Suffering From Acute Myocardial Infarction - Sitagrami Trial

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_gpad-ii_headshot
Arshed Ali Quyyumi

Emory University
Atlanta, GA
Effect of Progenitor Cell Mobilization with Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Patients with Peripheral Artery Disease and Claudication; GPAD-II: A Phase II Randomized Study

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
Related Science:

Back to Top

CS.02: Biomarkers in Populations
ss13_r3f_headshot
Eric Van Belle

Hôpital Cardiologique
Lille, France
Outcome Impact of Coronary Revascularization Strategy - Reclassification With Fractional Flow Reserve (FFR) at time of diagnostic angiography: Insights from a Large French Multicenter FFR Registry (R3F)

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_cpt1a_headshot
Stella Aslibekyan

University of Alabama at Birmingham
Birmingham, AL
CPT1A Methylation is a Novel Epigenetic Marker of Cardiovascular Risk

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_ontarioevents_headshot
Jack V. Tu

Institute for Clinical Evaluative Sciences
Toronto, ON, Canada
Ten-Year Incidence Rates of Maajor Cardiovascular Events in 697,690 Immigrants to Ontario, Canada, by Ethnic Group and Country of Birth

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_chinaprimarycare_headshot
Lijing L. Yan

The George Institute for Global Health at Peking University Health Science Center
Beijing, China
China Rural Health Initiative - Primary Care Provider Study: A Large Cluster-Randomized Controlled Trial of High Cardiovascular Risk Management in Rural China

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
Related Science:

Back to Top

CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis
ss13_bedtimeaspirin_headshot
Tobias Bonten

Leiden University Medical Center
Leiden, Netherlands
Does Aspirin Intake at Bedtime Decrease Blood Pressure and Morning Peak of Platelet Reactivity?: A Randomized Cross-over Trial

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_vitamind_headshot
Thomas J. Wang

Vanderbilt University
Nashville, TN
Daylight: Vitamin D Therapy in Individuals at High Risk of Hypertension

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_effervescent_headshot
Arshed Ali Quyyumi

Emory University
Atlanta, GA
Effect of Angiotensin II Type I Receptor Blockade on Carotid Artery Atherosclerosis: A Randomized Trial Comparing Valsartan and Placebo (EFFERVESCENT)

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_osler_headshot
Michael J. Koren

Jacksonville Center for Clinical Research, Jacksonville, FL
Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145 versus Standard of Care in 1104 Patients: 52-week Results from the OSLER Study

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
Related Science:

Back to Top

CS.04: Advanced Cardiovascular Disease: Complications and Challenges
ss13_kidneystatin_headshot
Amy Sarma

Brigham and Women's Hospital
Boston, MA
The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy after an Acute Coronary Syndrome

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio

ss13_first-in-man_headshot
Jeffrey H. Lawson

Duke University
Durham, NC

First-in-Man Clinical Evaluation of a Novel Tissue Engineered Vascular Graft

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
ss13_decrease_headshot
Joerg Schwab
University of Bonn
Bonn, Germany
 
Dedicated ICD Programming Reduces the Number of Inappropriate Therapies in a Real World Primary Prevention ICD Population: The DECREASE - Trial

Presentation Slides | Discussant Slides | Abstract | Presentation Audio
ss13_augment-hf_headshot
Douglas L. Mann

Washington University School of Medicine, Barnes Jewish Hospital
St. Louis, MO
A Multicenter, Randomized Study Assessing the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Advanced Heart Failure Patients with Ischemic and Non-ischemic Cardiomyopathy: Interim Results of the AUGMENT-HF Study

Presentation Slides | Discussant Slides | Abstract | Presentation Audio | Discussant Audio
Related Science:

Back to Top


Did You See? Clinical Practice Guidelines & Advisories for Prevention

AHA and ACC are pleased to announce the only comprehensive series of new cardiovascular prevention guidelines and advisories for the assessment and management of hypertension, cardiovascular risk, lifestyle modifications that reduce risk, management of elevated blood cholesterol, and management of increased body weight in adults. The guidelines are based on rigorous, comprehensive, systematic evidence reviews originally sponsored by the NHLBI. The ACC and AHA collaborated with professional organizations to finalize these AHA/ACC cardiovascular prevention guidelines and advisories, and stakeholder organizations were invited to review and endorse the final documents.
 


Learn at Heart

To support the implementation of these guidelines, the American Heart Association is making a series of web tools available for download now.

Narrated slidesets on the content of each guideline are available at learn.heart.org:

  • Assessment of Cardiovascular Risk
  • Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
  • Lifestyle Management to Reduce Cardiovascular Risk
  • Management of Overweight and Obesity in Adults

The new Pooled Cohort Equations CV Risk Calculator is available at my.americanheart.org/cvriskcalculator.
 

Related Science 



Supporting Materials


New Prevention Guidelines

NHLBI New Session Banner 280x280

Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Professional Online Network

Connect with over 30,000 heart and stroke professionals.

Be Heart Healthy at Sessions!

Sessions Fun Run Widget Image